Efavirenz 65862-0106-90
- Manufacturer
- Aurobindo Pharma Limited
- Dosage Form
- Capsule
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- December 15, 2017
- Listing Expires
- December 31, 2026
- Application
- ANDA078064
Need to source Efavirenz? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Efavirenz | 200 mg/1 |
Drug Class
Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]Cytochrome P450 2B6 Inducers [MoA]Cytochrome P450 2C19 Inhibitors [MoA]
Selected Package
65862-0106-90Selected90 CAPSULE in 1 BOTTLE (65862-106-90)
Other packages for this product(3)
9 BLISTER PACK in 1 CARTON (65862-106-09) / 10 CAPSULE in 1 BLISTER PACK
3 BLISTER PACK in 1 CARTON (65862-106-10) / 10 CAPSULE in 1 BLISTER PACK
30 CAPSULE in 1 BOTTLE (65862-106-30)